Compare Newegg Commerce Inc (NEGG) vs Twist Bioscience Corp (TWST) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Newegg Commerce Inc vs Twist Bioscience Corp — how do they compare? Newegg Commerce Inc trades at $19.7 (market cap $398.29M), while Twist Bioscience Corp trades at $123 (market cap $7.72B). The key difference: Twist Bioscience Corp is far larger — about 19.4× Newegg Commerce Inc's market cap, and Twist Bioscience Corp is trading nearer its 52-week high, Newegg Commerce Inc nearer its low. Which is the better fit depends on your goals.
| NEGG | TWST | |
|---|---|---|
Market Cap | $398.29M | $7.72B |
Sector | Consumer Cyclical | Health |
52-Week High | $128.09 | $124.88 |
52-Week Low | $12.87 | $24.16 |
Enterprise Value | $397.09M | $7.65B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
NEGG trades at $18.99, up 3.32% today, with a bullish technical signal from moving averages. Recent earnings beat expectations, showing improved profitability with a net income margin of 0.39% in 2025, up from negative margins in prior years. The company maintains a low P/S ratio of 0.28, but a high P/E of 73.16 reflects growth expectations. News highlights include AI shopping features and product launches, indicating innovation efforts.
Outlook: NEGG shows operational improvement with narrowing losses, but negative operating cash flow and high valuation multiples pose risks. The sole analyst coverage is bullish, yet investor caution is warranted due to competitive pressures and reliance on tech spending cycles. Upside depends on sustained revenue growth and margin expansion.
Twist Bioscience (TWST) trades at $123.76, down 0.9% on the day, with a bullish technical signal from moving averages but bearish oscillators. Revenue growth is strong, with 2025 revenue at $376.57 million, though the company remains unprofitable with a net income margin of -31.66%. Recent news highlights an upsized $300 million public offering and an analyst upgrade, contributing to positive sentiment.
The outlook is mixed: robust revenue growth and high analyst buy ratings (78.57%) support upside potential, but persistent losses, negative cash flow, and high valuation ratios pose significant risks. Investors should weigh the growth trajectory against the path to profitability and cash burn concerns.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Newegg Commerce Inc
Newegg Commerce Inc is an e-commerce company offering direct sales and an online marketplace platform for IT computer components, consumer electronics, entertainment, smart home and gaming products and provides certain third-party logistics services globally.
Read more on NEGG →About Twist Bioscience Corp
Twist Bioscience Corp is a synthetic biology company. It develops a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's DNA synthesis platform utilizes a proprietary semiconductor-based synthetic DNA manufacturing process that synthesizes DNA on silicon instead of on traditional well plastic plates to enable the production of high-quality synthetic DNA faster and affordable as well as overcomes inefficiencies. Powering cost-effective, rapid high-throughput synthesis, it enables researchers to rapidly realize opportunities ahead. Geographically, it derives a majority of revenue from the United States.
Read more on TWST →
